ESKAZOLE

This brand name is authorized in Austria, Australia, Estonia, Spain, France, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, Romania

Active ingredients

The drug ESKAZOLE contains one active pharmaceutical ingredient (API):

1 Albendazole UNII F4216019LN - ALBENDAZOLE

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. Read about Albendazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8459F
Country: EE	Ravimiamet	Identifier(s): 1146349, 1260616, 1300778, 1500387, 1736445
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60407
Country: FR	Base de données publique des médicaments	Identifier(s): 68879708
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2754
Country: JP	医薬品医療機器総合機構	Identifier(s): 6429007F1033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076071, 1088038
Country: MT	Medicines Authority	Identifier(s): AA565/32402, AA729/30101
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 134M92
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 35300
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65213002, W65213003, W65213004